Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. - Wikidata - wikimedia - TriplyDB

Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

http://www.wikidata.org/entity/Q37978202

about

Asymptomatic Hepadnaviral Persistence and Its Consequences in the Woodchuck Model of Occult Hepatitis B Virus Infection Hepatitis B and Hepatitis C Reactivation in the Biologic Era Cancer and liver cirrhosis: implications on prognosis and management Hepatitis B surface antigen seroconversion after HBV reactivation in non-Hodgkin's lymphoma.Persistence of hepatitis C virus during and after otherwise clinically successful treatment of chronic hepatitis C with standard pegylated interferon α-2b and ribavirin therapy Postexposure prophylactic effect of hepatitis B virus (HBV)-active antiretroviral therapy against HBV infection.Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo Practical review of immunizations in adult patients with cancer.Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents.Minicircle HBV cccDNA with a Gaussia luciferase reporter for investigating HBV cccDNA biology and developing cccDNA-targeting drugs.Hepatitis C virus and non-Hodgkin's lymphomas: A minireview.Reactivation of hepatitis viruses following immunomodulating systemic chemotherapy.Viral infections and their management in patients with chronic lymphocytic leukemia.Challenges in managing hepatitis C virus infection in cancer patients.Hepatitis C virus infection and risk of multiple myeloma: Evidence from a meta-analysis based on 17 case-control studies.Management of Multiple Myeloma Complicated by Hepatitis C Virus Reactivation: The Role of New Antiviral Therapy.Reactivation of Hepatitis C Virus and Its Clinical Outcomes in Patients Treated with Systemic Chemotherapy or Immunosuppressive Therapy.Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature.Hepatitis B virus-triggered autophagy targets TNFRSF10B/death receptor 5 for degradation to limit TNFSF10/TRAIL response.The oncologic burden of hepatitis C virus infection: A clinical perspective.Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study.Hepatitis B reactivation during everolimus treatment.How I treat hepatitis C virus infection in patients with hematologic malignancies.Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors.The value of serum Wisteria floribunda agglutinin-positive human Mac-2-binding protein as a predictive marker for hepatitis C virus-related complications after systemic chemotherapy.How I treat acute myeloid leukemia presenting with preexisting comorbidities.Hepatic encephalopathy associated with cancer or anticancer therapy.Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case series.The safety of chemotherapy for colorectal cancer patients with hepatitis C virus infection.Does the presence of hepatitis virus B and C influence the evolution of diffuse large B-cell lymphoma?Coadministration of telaprevir and transcatheter arterial chemoembolization in hepatitis C virus-associated hepatocellular carcinoma.Incidence and antiviral response of hepatitis C virus reactivation in lupus patients undergoing immunosuppressive therapy.Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.Active co-infection with HBV and/or HCV in South African HIV positive patients due for cancer therapy.Risk of hepatitis B infection in pediatric acute lymphoblastic leukemia in a tertiary care center from South India.Treatment of acute hepatitis C in breast cancer patient: a case report.Computerized physician order entry-based system to prevent HBV reactivation in patients treated with biologic agents: the PRESCRIB project.The effect of transcatheter arterial chemoembolization on hepatitis C viremia.A Novel Antiviral Treatment of Hepatitis C Virus Reactivation in a Breast Cancer Patient Undergoing Chemotherapy.Hepatitis B reactivation related to everolimus.

P2860

Q26775638-A7C5503A-04B7-4D52-A083-C32305D31D71 Q26781993-798FD6A9-6AD0-4951-9CDA-AF9E7E5F89AF Q28068579-E6278FCB-EF03-43D6-9A86-A5A2A98E191D Q33564294-65184C90-5812-4983-9107-E0C3AB38D993 Q35053440-D34264BE-6C94-4689-9DA0-122A8F1B20B3 Q35105851-387E543F-BBD6-41ED-A8CC-1A3B00A3EF3E Q36216315-5BF64481-9BAF-48DC-809C-044A6D2769B8 Q36388960-848036B6-7135-4C14-B112-D390146F9551 Q36790040-E244D08F-4973-4B61-862B-79A9113853D5 Q37397410-758851BF-EB69-4FF6-B454-9FD07F74D1AF Q37610899-C3780904-9B10-4119-907A-4458D01E30C3 Q38062943-311FE17D-3001-49EC-AC98-760E0B4965F8 Q38064527-932EC28F-DAF6-4B18-B78F-A67D28E772D1 Q38198615-2287E48F-65BC-48F5-BBA8-C36DBD27BB47 Q38370061-F1BFA425-D051-486D-810F-E7189B538589 Q38377322-0CD68863-FBF2-4963-A74C-A4A33B6AF7AE Q38657207-7F5FA99B-BD0C-4B1F-9310-A83A7DFB112A Q38793776-A83A59EB-4164-419D-9B38-0CBE7F48221F Q39291816-5AC26775-EA58-43D5-A525-6AC720BF6950 Q39418450-66CCA7C1-2CDA-4E89-AF03-D5A8F0B92880 Q40144152-0255EF86-0112-483F-99A7-C54B3B0DDFBE Q40521465-AA4EDA59-CD2C-4F7E-8428-2546F23482D7 Q40604797-CD552945-3FF8-44EF-8361-26C6D063027D Q40691267-556E0D12-CFBB-47B7-B0F7-23819899E64B Q40722284-C64A130C-6008-4C0C-9194-5759BC700166 Q41107043-03F58039-9D01-4437-A43F-C0C88C20323A Q41111818-023C153E-73E7-4200-BC45-A98676C26D3A Q41700506-08192E20-4B47-473B-8D53-DFE2567DA167 Q41732527-346F8A02-4704-439A-817D-5F689FED21F6 Q41740108-21943E1A-3EB8-47A6-A9EA-3BF24E7BC5B0 Q42101421-B06BDE5A-F49C-487A-AD1C-A73C1100191B Q42162220-57EA8E12-5570-4B02-B159-DF11CEDB0D80 Q42182001-754B8F79-9D2F-4C72-9105-03B5EE2A7E4E Q42197952-7655729A-BF42-4D84-8247-46731B0F61C2 Q42220392-0AA8600F-AA29-4D77-AFDE-CB3AE5D4A106 Q42232094-61467911-35A0-4108-8E85-C1CC88504977 Q42234350-6A5E7C66-A0A4-478A-84AF-926DAC2CBEAE Q42326706-FEF1343E-B539-4CB6-A7D8-932BFEDA3B5F Q42345319-E21A9C81-233B-4D88-8088-0B4C310FF69A Q43138872-69F92E17-B83B-4D41-9D76-FD17DF5B305E

P2860

Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

http://www.wikidata.org/entity/Q37978202

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

@en

Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

@nl

type

label

Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

@en

Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

@nl

prefLabel

Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

@en

Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

@nl

P1433

Q37978202-2A6D0AE5-F2CD-40CB-8405-AE675603B26C

P1476

Q37978202-4E343B02-F5A3-4DF2-B629-4FE8D66245B3

P2093

Q37978202-4302BFBD-4498-4FC4-A2DE-8932941443AF

Q37978202-AA8F07C4-71DA-4381-8F5C-643717AD4D0E

P2860

Q37978202-00DCB446-EDF9-49A7-BE7E-E3BF2AE125AA

Q37978202-0206FF48-BBB5-4153-8753-800C742AFAA5

Q37978202-087DECD4-D440-4A04-B0C9-292709FC1D9A

Q37978202-08B5FDDC-19D3-4A29-BAAD-A50CBC2EF320

Q37978202-09ACE902-00A2-48E3-91F5-6EFD81FFABEF

Q37978202-0CD63F4F-C473-44ED-831C-5BB612EA56CB

Q37978202-0DC50F32-7769-47A4-85C8-02B517847016

Q37978202-10CB0B2C-493A-478A-98FD-50A51BBD7AA0

Q37978202-1B7C4CFB-11BB-49D6-8583-88489D98F120

Q37978202-1E711175-10A5-4524-A150-04307BD4C180

P304

Q37978202-0574DA9D-CBD7-4EE3-90EC-B02037BB09FD

P31

Q37978202-B14F4F02-5FEA-432E-9F0E-B5C9F9425F87

P356

Q37978202-2901DC7F-0472-4AB6-830A-5CE49AE1E317

P407

Q37978202-5E78DF81-017D-49F5-9086-817DA2D7B031

P433

Q37978202-3EB36630-003A-4894-A541-B65CD9612699

P478

Q37978202-4946CC78-172D-4055-A949-68B55E4772FF

P577

Q37978202-B15EB8F9-D1FB-4B12-ADD1-8427980C04AF

P5875

Q37978202-079DEDF2-E6BE-42F7-8D05-C8DFAD2864AF

P698

Q37978202-BB462922-3101-45E2-9A60-3789FCEB3296

P921

Q37978202-F0F07196-556C-4EBA-8C82-D20D5C8ACAB8

P356

NRCLINONC.2012.1

P1433

Nature Reviews Clinical Oncology

P1476

Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

@en

P2093

Harrys A Torres

http://www.w3.org/2001/XMLSchema#string

Marta Davila

http://www.w3.org/2001/XMLSchema#string

P2860

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

Improving the Diagnosis of Acute Hepatitis C Virus Infection with Expanded Viral Load Criteria

Replication of hepatitis C virus

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

Diagnosis, management, and treatment of hepatitis C: an update

Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy.

Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem.

Chronic hepatitis B.

Hepatitis C and B-cell lymphoma.

Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy.

P304

156-166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCLINONC.2012.1

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221771622

http://www.w3.org/2001/XMLSchema#string

P698

22271089

http://www.w3.org/2001/XMLSchema#string

P921